Keiichi Yuwaki1,2, Aya Kuchiba3, Aki Otsuki1, Miyuki Odawara4, Tsuyoshi Okuhara5, Hirono Ishikawa6, Manami Inoue1, Shoichiro Tsugane1, Taichi Shimazu7. 1. Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku, Tokyo, Japan. 2. Underwriting and Medical Department, The Dai-ichi Life Insurance Company, Limited, Koto-ku, Tokyo, Japan. 3. Division of Biostatistical Research, Center for Public Health Sciences/Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Chuo-ku, Tokyo, Japan. 4. Behavioral Sciences and Survivorship Research Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku, Tokyo, Japan. 5. Department of Health Communication, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan. 6. Teikyo University Graduate School of Public Health, Itabashi-ku, Tokyo, Japan. 7. Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Chuo-ku, Tokyo, Japan. tshimazu@ncc.go.jp.
Authors: Xianglong Xu; Zongyuan Ge; Eric P F Chow; Zhen Yu; David Lee; Jinrong Wu; Jason J Ong; Christopher K Fairley; Lei Zhang Journal: J Clin Med Date: 2022-03-25 Impact factor: 4.241